Banque Pictet & Cie Sa Catalent, Inc. Transaction History

Banque Pictet & Cie Sa

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$45.44 - $74.26 $3.36 Million - $5.5 Million	74,010 Added 612.87%	86,086 $5.66 Million
Q4 2022 Feb 06, 2023	BUY	$41.39 - $81.0 $499,825 - $978,156	12,076 New	12,076 $0
Q2 2022 Aug 08, 2022	BUY	$87.2 - $114.05 $127,486 - $166,741	1,462 Added 48.77%	4,460 $479,000
Q1 2022 May 04, 2022	BUY	$94.19 - $124.49 $282,381 - $373,221	2,998 New	2,998 $333,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.